| Year |
Citation |
Score |
| 2014 |
Hulse RP, Beazley-Long N, Hua J, Kennedy H, Prager J, Bevan H, Qiu Y, Fernandes ES, Gammons MV, Ballmer-Hofer K, Gittenberger de Groot AC, Churchill AJ, Harper SJ, Brain SD, Bates DO, et al. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiology of Disease. 71: 245-59. PMID 25151644 DOI: 10.1016/J.Nbd.2014.08.012 |
0.835 |
|
| 2013 |
Beazley-Long N, Hua J, Jehle T, Hulse RP, Dersch R, Lehrling C, Bevan H, Qiu Y, Lagrèze WA, Wynick D, Churchill AJ, Kehoe P, Harper SJ, Bates DO, Donaldson LF. VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. The American Journal of Pathology. 183: 918-29. PMID 23838428 DOI: 10.1016/J.Ajpath.2013.05.031 |
0.845 |
|
| 2012 |
Qiu Y, Seager M, Osman A, Castle-Miller J, Bevan H, Tortonese DJ, Murphy D, Harper SJ, Fraser HM, Donaldson LF, Bates DO. Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility. Reproduction (Cambridge, England). 143: 501-11. PMID 22232745 DOI: 10.1530/Rep-11-0091 |
0.786 |
|
| 2011 |
Bevan HS, Slater SC, Clarke H, Cahill PA, Mathieson PW, Welsh GI, Satchell SC. Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase. American Journal of Physiology. Renal Physiology. 301: F733-42. PMID 21775480 DOI: 10.1152/Ajprenal.00458.2010 |
0.362 |
|
| 2010 |
Qiu Y, Ferguson J, Oltean S, Neal CR, Kaura A, Bevan H, Wood E, Sage LM, Lanati S, Nowak DG, Salmon AH, Bates D, Harper SJ. Overexpression of VEGF165b in podocytes reduces glomerular permeability. Journal of the American Society of Nephrology : Jasn. 21: 1498-509. PMID 20688932 DOI: 10.1681/Asn.2009060617 |
0.643 |
|
| 2010 |
Magnussen AL, Rennel ES, Hua J, Bevan HS, Beazley Long N, Lehrling C, Gammons M, Floege J, Harper SJ, Agostini HT, Bates DO, Churchill AJ. VEGF-A165b is cytoprotective and antiangiogenic in the retina. Investigative Ophthalmology & Visual Science. 51: 4273-81. PMID 20237249 DOI: 10.1167/Iovs.09-4296 |
0.846 |
|
| 2009 |
Woolard J, Bevan HS, Harper SJ, Bates DO. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation (New York, N.Y. : 1994). 16: 572-92. PMID 19521900 DOI: 10.1080/10739680902997333 |
0.819 |
|
| 2008 |
Bevan HS, Van Den Akker NMS, Qiu Y, Polman JAE, Foster RR, Yem J, Nishikawa A, Satchell SC, Harper SJ, Gittenberger-De Groot AC, Bates DO. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGF xxxb in human kidney development Nephron - Physiology. 110. PMID 19039247 DOI: 10.1159/000177614 |
0.825 |
|
| 2008 |
Varey AHR, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, Harper SJ, Bates DO. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy British Journal of Cancer. 98: 1366-1379. PMID 18349829 DOI: 10.1038/Sj.Bjc.6604308 |
0.83 |
|
| 2008 |
Qiu Y, Bevan H, Weeraperuma S, Wratting D, Murphy D, Neal CR, Bates DO, Harper SJ. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b Faseb Journal. 22: 1104-1112. PMID 18032632 DOI: 10.1096/Fj.07-9718Com |
0.754 |
|
| 2008 |
Bevan HS, Akker NMSvd, Qiu Y, Polman JAE, Foster RR, Yem J, Nishikawa A, Satchell SC, Harper SJ, Groot ACG, Bates DO. Contents Vol. 110, 2008 Nephron Physiology. 110. DOI: 10.1159/000187120 |
0.428 |
|
| 2006 |
Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clinical Science (London, England : 1979). 110: 575-85. PMID 16451124 DOI: 10.1042/Cs20050292 |
0.771 |
|
| 2004 |
Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Research. 64: 7822-35. PMID 15520188 DOI: 10.1158/0008-5472.Can-04-0934 |
0.813 |
|
| 2004 |
Bevan HS, Qiu Y, Foster R, Digby-Bell J, Harper SJ, Bates DO. PC31 EXPRESSION OF THE INHIBITORY VEGF ISOFORM VEGF 165b IN HUMAN KIDNEY Microcirculation. 11: 549-549. DOI: 10.1080/10739680490488706 |
0.804 |
|
| 2004 |
Bevan HS, Woolard J, Harper SJ, Bates DO. OC21 VEGF165b INHIBITS VEGF165 MEDIATED VEGF-R2 PHOSPHORYLATION AND AKT PHOSPHORYLATION Microcirculation. 11: 536-536. DOI: 10.1080/10739680490488319 |
0.684 |
|
| Show low-probability matches. |